Source: International Congress 2014 – Multidrug-resistant (MDR) pathogens that cause pneumonia
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
F. Blasi (Milan, Italy). Resistant pathogens that cause pneumonia: a global perspective. International Congress 2014 – Multidrug-resistant (MDR) pathogens that cause pneumonia

Member's Comments

No comment yet.

Related content which might interest you: Bacterial pneumonia in children: a global perspective Source: International Congress 2018 – State of the art session: Paediatric respiratory diseases Year: 2018 Predicting bacteraemia or rapid identification of the causative pathogen in community acquired pneumonia: where should the priority lie? Source: Eur Respir J 2016; 48: 619-622 Year: 2016 Healthcare associated pneumonia does not accurately identify potentially resistant pathogens: A systematic evaluation Source: Annual Congress 2013 –Interesting research questions Year: 2013 Bacteraemia and antibiotic-resistant pathogens in community acquired pneumonia: risk and prognosis Source: Eur Respir J 2015; 45: 1353-1363 Year: 2015 Frequency of multidrug resistant pathogens in healthcare associated pneumonia Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections Year: 2014 Common organisms causing community acquired pneumonia Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections Year: 2013 Multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia Source: Annual Congress 2013 –Recent developments in pneumonia Year: 2013 Treating nosocomial pneumonia: what's new Source: ERJ Open Res, 4 (2) 00058-2018; 10.1183/23120541.00058-2018 Year: 2018 Potential antibiotic resistant pathogens in community-acquired pneumonia: playing it safe is anything but Source: Eur Respir J, 54 (1) 1900870; 10.1183/13993003.00870-2019 Year: 2019 Ventilator-associated pneumonia: risk factors for antimicrobial-resistant causative pathogens Source: Eur Respir J 2006; 28: Suppl. 50, 785s Year: 2006 Improving outcomes from community-acquired pneumonia: we need to be more sophisticated about cause and effect Source: Eur Respir J 2011; 39: 7-8 Year: 2012 Improving outcomes from community-acquired pneumonia: we need to be more sophisticated about cause and effect Source: Eur Respir J 2012; 39: 7-8 Year: 2012 Community-acquired pneumonia in Europe: causative pathogens and resistance patterns Source: Eur Respir J 2002; 20: 20S-27S Year: 2002 The risk factors of clinical practice for bacteremia in community- acquired pneumococcal pneumonia Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016 Late Breaking Abstract - Biomarkers for iron metabolism among patients hospitalized with community-acquired pneumonia caused by SARS-CoV-2, bacteria, and influenza Source: Virtual Congress 2021 – Diagnosis and management of COVID-19 Year: 2021 Is health care-associated pneumonia itself a predisposing factor for multi-drug resistant organisms? Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia Year: 2019 Impact of bacterial coinfection on clinical outcomes in pneumococcal pneumonia Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015 The impact of mixed etiology in community acquired pneumonia (CAP) Source: International Congress 2014 – Respiratory infections: inflammation and treatment Year: 2014